Health Insurance Companies Aim to Streamline Care Processes
The top health insurance firms in the country are taking steps to address and improve issues that have contributed to delays in patient care and associated complications.
UnitedHealthcare, Aetna (part of CVS Health), along with numerous other insurers, have announced plans to narrow the types of medical claims that require advance approval. They also intend to standardize processes and enhance real-time responses.
Advance approval is when an insurance provider mandates authorization before covering certain services, including medical treatments, prescriptions, or imaging studies. Insurers claim this practice helps prevent unnecessary care and ensures that patients receive appropriate treatments.
However, many doctors argue that these requirements have become overly complex, leading to frequent delays in care. A notable incident involved UnitedHealthcare’s CEO Brian Thompson addressing frustrations over compensation issues linked to pre-approvals.
During a recent Senate confirmation hearing, Dr. Mehmet Oz criticized the system for increasing administrative costs. He is now leading the Centers for Medicare and Medicaid Services.
On Monday, insurance companies stated their intention to standardize electronic pre-authorization by the end of next year, which should help expedite the process. They plan to reduce the scope of claims requiring advance approvals and to honor previous pre-approvals if a patient changes plans.
Moreover, they aim to increase the number of real-time responses and ensure that medical reviews are conducted for any denied requests.
Researchers have noted that as healthcare costs have surged—particularly for medications, lab tests, physical therapy, and imaging—pre-approval has become increasingly common.
Michael Anne Kyle, an assistant professor at the University of Pennsylvania, commented on ongoing efforts to address these issues.
For many enrolled in Medicare Advantage Plans run by the federal government, prior authorization is mandatory for some services, especially costly procedures like hospital stays. A recent survey revealed that around 6% of all requests are denied by insurance companies.
Dr. Ashley Sumrall, an oncologist in Charlotte, North Carolina, observed that the number of pre-approvals needed for routine tests, such as MRIs, has risen significantly. These scans are vital for determining treatment effectiveness and planning subsequent steps for patients battling brain tumors.
Delays in receiving approved requests or compensation can adversely affect patients by allowing disease progress while treatment is stalled. This can heighten anxiety among those eager to learn if their tumors are stable and whether their scans are covered by insurance.
There’s actually a term for this anxiety—”scanxiety”—which reflects a very real concern, as noted by Sumrall, who is also part of the Association of Volunteer Leadership in Clinical Oncology.
Additionally, the varied pre-authorization requirements across different insurers add to the confusion. Each company operates differently, according to Sumrall.
For years, insurers were reluctant to be flexible, so steps toward standardization could be a positive development, she said.
Insurance providers maintain that their commitments will affect compensation across various markets, including individual policies, Medicare Advantage Plans, and both state and federally funded Medicaid programs.
